Stereotactic radiosurgery as effective in eliminating Parkinson's disease tremors as other treatments but less invasive

November 2, 2009

Stereotactic radiosurgery (SRS) offers a less invasive way to eliminate tremors caused by Parkinson's disease and essential tremor than deep brain stimulation (DBS) and radiofrequency (RF) treatments, and is as effective, according to a long-term study presented November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

"The study shows that radiosurgery is an effective and safe method of getting rid of tremors caused by Parkinson's disease and essential tremor, with outcomes that favorably compare to both DBS and RF in tremor relief and risk of complications at seven years after treatment," Rufus Mark, M.D., an author of the study and a radiation oncologist at the Joe Arrington Cancer Center and Texas Tech University, both in Lubbock, Texas said. "In view of these long-term results, this non-invasive procedure should be considered a primary treatment option for tremors that are hard to treat."

Parkinson's disease is a slowly progressive neurologic disease that causes tremors, in addition to other symptoms. Essential tremor is the most common of all movement disorders and causes uncontrollable shaking of the hands, head, and sometimes other parts of the body.

Stereotactic radiation is a specialized type of external beam that pinpoints high doses of radiation directly on a confined area in a shorter amount of time than traditional radiation treatments. Stereotactic radiosurgery, or SRS, refers to a single or several stereotactic radiation treatments of the brain or spine. SRS is delivered by a team involving a radiation oncologist and a neurosurgeon. This is often called by the brand
names of the manufacturers, including Axesse, CyberKnife, Gamma Knife, Novalis, Primatom, Synergy, X-Knife, TomoTherapy and Trilogy.

Between 1991 and 2007, 183 patients underwent stereotactic radiosurgery thalamotomy, for hard-to-treat tremors caused by Parkinson's disease and essential tremors. A thalamotomy is a procedure that destroys tissue at a particular spot—the Ventralis Inter-Medius nucleus—on the thalamus of the brain which influences movement.

With a median follow-up of seven years, 84 percent of patients had significant or complete resolution of tremors. In patients with Parkinson's disease, 83 percent had near or complete tremor resolution, while those with essential tremor had 87 percent of this degree of tremor resolution.

Source: American Society for Radiation Oncology

Related Stories

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.